Valneva SE

Status: Publicly traded

Direct answer

Valneva SE is publicly traded on PAR under the ticker VLA.PA.

Valneva SE is a specialized biotechnology company focused on developing and bringing to market preventative vaccines for infectious diseases with significant unmet medical needs. Their commercial offerings for travelers include IXIARO, a vaccine against Japanese encephalitis, and DUKORAL, an oral vaccine designed to protect against diarrhea caused by Vibrio cholera and specific heat-labile toxin-producing...

Can you invest in Valneva SE?

Yes. Valneva SE is publicly traded on PAR under the ticker VLA.PA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Valneva SE

Detailed equity research is provided by MarketSnap.